{
    "Trade/Device Name(s)": [
        "Alere\u2122 i Influenza A & B",
        "Alere\u2122 i flu",
        "Alere\u2122 i",
        "Alere\u2122 Influenza A & B"
    ],
    "Submitter Information": "Alere Scarborough, Inc.",
    "510(k) Number": "K151464",
    "Predicate Device Reference 510(k) Number(s)": [
        "K141520"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OCC",
        "OZE",
        "OOI"
    ],
    "Summary Letter Date": "June 02, 2015",
    "Summary Letter Received Date": "June 03, 2015",
    "Submission Date": "July 8, 2015",
    "Regulation Number(s)": [
        "21 CFR 866.3980",
        "21 CFR 862.2570"
    ],
    "Regulation Name(s)": [
        "Respiratory Viral Panel Multiplex Nucleic Acid Assay",
        "Instrumentation for Clinical Multiplex Test Systems"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology",
        "POCT"
    ],
    "Analyte(s)": [
        "Influenza A viral RNA",
        "Influenza B viral RNA"
    ],
    "Specimen Type(s)": [
        "Direct nasal swab",
        "Nasal swab eluted in viral transport media",
        "Nasopharyngeal swab eluted in viral transport media"
    ],
    "Specimen Container(s)": [
        "Sample Receiver (with elution buffer)",
        "Test Base",
        "Transfer Cartridge",
        "Viral transport media"
    ],
    "Instrument(s)/Platform(s)": [
        "Alere\u2122 i Instrument",
        "Alere\u2122 Universal Printer"
    ],
    "Method(s)/Technology(ies)": [
        "Isothermal nucleic acid amplification",
        "Fluorescence detection"
    ],
    "Methodologies": [
        "Qualitative detection",
        "Molecular amplification testing",
        "Automated result interpretation"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "System",
        "Instrument",
        "Reagent",
        "Reader",
        "Cartridge",
        "Consumable"
    ],
    "Document Summary": "FDA 510(k) summary for Alere\u2122 i Influenza A & B rapid molecular test for qualitative detection and discrimination of influenza A and B RNA from nasal and nasopharyngeal swabs using isothermal amplification on the Alere\u2122 i Instrument",
    "Indications for Use Summary": "Rapid molecular in vitro diagnostic test utilizing isothermal nucleic acid amplification to detect and differentiate influenza A and B viral RNA in direct nasal swabs or swabs eluted in viral transport media from patients with respiratory infection symptoms, as an aid in differential diagnosis of influenza A and B infections in conjunction with clinical and epidemiological risk factors",
    "fda_folder": "Microbiology"
}